Being overweight and obese contributes to numerous health conditions, including cardiovascular disease, diabetes, sleep and musculoskeletal disorders, stroke, hormonal issues, certain cancers and a decreased lifespan
Studies show that people on higher doses of tirzepatide often lose an average of 15 to 21% of their starting weight over about a year or more
If theres still no drop, dont use the pen and contact Novo Nordisk at 1-888-693-6742
As next steps, we need larger and longer studies involving more diverse groups of patients
The study concluded that TCC led to faster healing and more granulation tissue formation compared to zinc oxide or no treatment, positioning TCC as a better choice for open-wound management in rabbits [2]